Cerveny, Daniel
- Department of Wildlife, Fish and Environmental Studies, Swedish University of Agricultural Sciences
- University of South Bohemia in České Budějovice
Research article2021Peer reviewedOpen access
Cerveny, Daniel; Fick, Jerker; Klaminder, Jonatan; Bertram, Michael; Brodin, Tomas
It is generally expected that biotransformation and excretion of pharmaceuticals occurs similarly in fish and mammals, despite significant physiological differences. Here, we exposed European perch (Perca fluviatilis) to the benzodiazepine drug temazepam at a nominal concentration of 2 µg L−1 for 10 days. We collected samples of blood plasma, muscle, and brain in a time-dependent manner to assess its bioconcentration, biotransformation, and elimination over another 10 days of depuration in clean water. We observed rapid pharmacokinetics of temazepam during both the exposure and depuration periods. The steady state was reached within 24 h of exposure in most individuals, as was complete elimination of temazepam from tissues during depuration. Further, the biologically active metabolite oxazepam was produced via fish biotransformation, and accumulated significantly throughout the exposure period. In contrast to human patients, where a negligible amount of oxazepam is created by temazepam biotransformation, we observed a continuous increase of oxazepam concentrations in all fish tissues throughout exposure. Indeed, oxazepam accumulated more than its parent compound, did not reach a steady state during the exposure period, and was not completely eliminated even after 10 days of depuration, highlighting the importance of considering environmental hazards posed by pharmaceutical metabolites.
metabolic transformation; metabolite; pharmaceutical; psychoactive drug; fish; accumulation; depuration
Ecotoxicology and Environmental Safety
2021, volume: 217, article number: 112246
SDG3 Good health and well-being
SDG14 Life below water
Fish and Aquacultural Science
https://res.slu.se/id/publ/111726